Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Atypical antipsychotic use in patients with dementia: managing safety concerns.

Steinberg M, Lyketsos CG.

Am J Psychiatry. 2012 Sep;169(9):900-6. doi: 10.1176/appi.ajp.2012.12030342.

2.
3.

The efficacy and safety of atypical antipsychotics for the treatment of dementia: a meta-analysis of randomized placebo-controlled trials.

Ma H, Huang Y, Cong Z, Wang Y, Jiang W, Gao S, Zhu G.

J Alzheimers Dis. 2014;42(3):915-37. doi: 10.3233/JAD-140579.

PMID:
25024323
4.

Behavioral disturbances of dementia.

Pollock BG, Mulsant BH.

J Geriatr Psychiatry Neurol. 1998 Winter;11(4):206-12. Review.

PMID:
10231000
5.

Atypical antipsychotics for neuropsychiatric symptoms of dementia: malignant or maligned?

Herrmann N, Lanctôt KL.

Drug Saf. 2006;29(10):833-43. Review.

PMID:
16970508
6.

Using antipsychotic agents in older patients.

Alexopoulos GS, Streim J, Carpenter D, Docherty JP; Expert Consensus Panel for Using Antipsychotic Drugs in Older Patients..

J Clin Psychiatry. 2004;65 Suppl 2:5-99; discussion 100-102; quiz 103-4. Review.

7.

Profile of atypical-antipsychotics use in patients affected by dementia in the University Hospital of Ferrara.

Chiabrando G, Bianchi S, Poluzzi E, Montanaro N, Scanavacca P.

Eur J Clin Pharmacol. 2010 Jul;66(7):661-9. doi: 10.1007/s00228-010-0828-z. Epub 2010 May 13.

PMID:
20464383
8.
9.

Alternatives to atypical antipsychotics for the management of dementia-related agitation.

Passmore MJ, Gardner DM, Polak Y, Rabheru K.

Drugs Aging. 2008;25(5):381-98. Review.

PMID:
18447403
10.

Withdrawal versus continuation of chronic antipsychotic drugs for behavioural and psychological symptoms in older people with dementia.

Declercq T, Petrovic M, Azermai M, Vander Stichele R, De Sutter AI, van Driel ML, Christiaens T.

Cochrane Database Syst Rev. 2013 Mar 28;(3):CD007726. doi: 10.1002/14651858.CD007726.pub2. Review.

PMID:
23543555
11.

Use and safety of antipsychotics in behavioral disorders in elderly people with dementia.

Gareri P, De Fazio P, Manfredi VG, De Sarro G.

J Clin Psychopharmacol. 2014 Feb;34(1):109-23. doi: 10.1097/JCP.0b013e3182a6096e. Review.

PMID:
24158020
12.

Summary of the comparative effectiveness review on off-label use of atypical antipsychotics.

Maher AR, Theodore G.

J Manag Care Pharm. 2012 Jun;18(5 Suppl B):S1-20. Review.

PMID:
22784311
13.

Are atypical antipsychotics safer than typical antipsychotics for treating behavioral and psychological symptoms of dementia?

Gurevich A, Guller V, Berner YN, Tal S.

J Nutr Health Aging. 2012;16(6):557-61. Review.

PMID:
22659997
14.

Efficacy and adverse effects of atypical antipsychotics for dementia: meta-analysis of randomized, placebo-controlled trials.

Schneider LS, Dagerman K, Insel PS.

Am J Geriatr Psychiatry. 2006 Mar;14(3):191-210.

PMID:
16505124
15.
16.
17.

Risperidone for the treatment of neuropsychiatric features in dementia.

Burns A, De Deyn PP.

Drugs Aging. 2006;23(11):887-96. Review.

PMID:
17109567
18.

Update on neuropsychiatric symptoms of dementia: antipsychotic use.

Kalapatapu RK, Schimming C.

Geriatrics. 2009 May;64(5):10-8.

PMID:
19435390
19.
20.

Pharmacotherapy for behavioral and psychological symptoms of dementia in the elderly.

Beier MT.

Am J Health Syst Pharm. 2007 Jan 15;64(2 Suppl 1):S9-17; quiz S24-5.

PMID:
17215476

Supplemental Content

Support Center